The growing computational bottleneck of von Neumann systems underscores the urgent need for a brain-inspired, energy-efficient approach. In response, a fully biocompatible multiterminal neuromorphic biodevice was developed using an acellular dermal matrix (ADM) as a biocompatible substrate, polylact …
Expect a lot of biotech papers authored by Chinese geniuses that are incomprehensible to anybody. None of the limitations on other high-tech fields (such as semiconductors) in China apply to biotech. In fact, they have some key advantages, like regional clinics that get hooked into public insurance & end up with gargantuan datasets. This will only get better as medicine is less centered around China’s east coast, but for the time being that bottleneck has some upsides too.
Expect a lot of biotech papers authored by Chinese geniuses that are incomprehensible to anybody. None of the limitations on other high-tech fields (such as semiconductors) in China apply to biotech. In fact, they have some key advantages, like regional clinics that get hooked into public insurance & end up with gargantuan datasets. This will only get better as medicine is less centered around China’s east coast, but for the time being that bottleneck has some upsides too.